Brokerage Firm Target Review on T2 Biosystems, Inc. (NASDAQ:TTOO)

During the most recent trading session, shares of T2 Biosystems, Inc. (NASDAQ:TTOO) ¬†changed N/A. Street analysts that track the company are anticipating the stock to go to $7.21 within the next year. Target price projections may vary greatly depending on the specific analyst providing data. This consensus target is compiled using analysts polled by Thomson Reuters. 

Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. T2 Biosystems, Inc. currently has a P/E Ratio of N/A. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of 0.00.

Looking at stock performance, company shares have recently traded $-0.72 away from the 50-day moving average of $6.55 and $-1.27 away from the 200-day moving average of $7.10. The stock has been recently noted -51.42% off of the 52-week high of 12.00 and +18.50% off of the 52-week low of 4.92. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.